Evidence check: HbA1c in the context of gut health

HbA1c (glycated hemoglobin) is a well-established clinical marker reflecting average blood glucose over the past 2–3 months, primarily used for diabetes diagnosis and monitoring. A direct link to gut health is not scientifically proven. There is emerging evidence that the gut microbiome can influence glucose metabolism – for example via short-chain fatty acids or endotoxins – but most data are mechanistic or from small human studies. An elevated HbA1c may indicate impaired glucose tolerance, which can be associated with altered gut microbiota composition. However, HbA1c is not a specific gut health marker. If you see HbA1c in a gut or DNA test report, understand that it is a general metabolic parameter. Interpreting it solely as a sign of gut dysfunction is not supported. Clinically abnormal values require medical follow-up (e.g., fasting glucose, OGTT). The evidence for a direct causal relationship between gut health and HbA1c is currently mixed.